# CAR-T
Latest news and articles about CAR-T
Total: 2 articles found
Technology
CSPC Pharma Pivots to Next-Gen Cell Therapy with mRNA-Based CAR-T Clinical Approval
CSPC Pharmaceutical Group has received Chinese regulatory approval to begin clinical trials for SYS6063, a dual-target CAR-T therapy delivered via mRNA-LNP technology. This milestone reflects a strategic shift toward non-viral delivery systems that could make advanced cancer treatments more scalable and cost-effective.
NeTe2026年6月2日 11:08
#CSPC Pharmaceutical#mRNA#CAR-T
Business
Eli Lilly Bets $7 Billion on the ‘Holy Grail’ of Cancer Therapy to Diversify Beyond Weight Loss
Eli Lilly is acquiring Kelonia Therapeutics for up to $7 billion to gain access to its revolutionary in-vivo CAR-T technology. This strategic move aims to diversify Lilly's portfolio beyond its successful weight-loss business and establish a leading position in the high-growth oncology market.
NeTe2026年4月20日 17:58
#Eli Lilly#Kelonia Therapeutics#Oncology